Merck | MRK - Net Income

Stock Price
111.90
Daily Change
-2.72 -2.37%
Monthly
-6.26%
Yearly
35.24%
Q2 Forecast
109.51

Merck reported $2.96B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Abbott USD 1.08B 699M Mar/2026
ALKERMES USD 49.34M 33.42M Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Drreddys Laboratories INR 12.1B 2.08B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Glaxosmithkline GBP 846.06M 1.87B Dec/2025
J&J USD 5.24B 119M Mar/2026
Medtronic USD 1.14B 231M Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Novo Nordisk DKK 26.89B 388M Dec/2025
Pacira USD 1.64M 3.8M Dec/2025
Perrigo USD -1.42B 1.43B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
Sanofi EUR -801M 3.6B Dec/2025
United Therapeutics USD 364.3M 25.6M Dec/2025
Zoetis USD 603M 118M Dec/2025